Supplementary Table 3.
Author, Year | Comparator Time From FIT | Alternate Time Cutoffs | Outcomes | Detailed Results | Summary |
---|---|---|---|---|---|
Gellad, 200942 | Continuous | Continuous | Incidence of CRC or advanced adenoma(s) (at colonoscopy) |
|
Incremental delays to colonoscopy of 1 mo after positive FOBT were associated with a nonsignificant trend toward higher incidence of CRC and advanced adenomas combined. This study was limited by sample size. |
Flugelman, 201918 | Within 3 mo | Within 4–6, 7–12, >12 mo | CRC-specific mortality |
|
Delays to colonoscopy of 12 mo or more after positive FOBT were significantly associated with higher CRC-specific mortality (compared with performing colonoscopy within 3 mo). |
Beshara, 202017 | Within 3 mo | 4–6, 7–9, 10–12, 13–18, 19–24 mo |
CRC incidence (at colonoscopy) CRC stage |
|
Delays to colonoscopy of 12 mo or more after positive FOBT were significantly associated with higher CRC incidence and more advanced stage of diagnosis (compared with performing colonoscopy within 3 mo). |
AOR, adjusted odds ratio; CI, confidence interval; CRC, colorectal cancer; FIT, fecal immunochemical test; FOBT, fecal occult blood test; HR, hazard ratio; OR, odds ratio.